Long-term Safety Follow-up in Recipients Who Previously Received Medeor's Cellular Immunotherapy Products

NCT05010174 · clinicaltrials.gov ↗
TERMINATED
Status
5
Enrollment
INDUSTRY
Sponsor class

Stopped Lack of funding

Conditions

Interventions

Sponsor

Medeor Therapeutics, Inc.